Ibutilide

In the US, Ibutilide (ibutilide systemic) is a member of the drug class group III antiarrhythmics and is used to treat Atrial Fibrillation and Atrial Flutter.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01BD05

CAS registry number (Chemical Abstracts Service)

0122647-31-8

Chemical Formula

C20-H36-N2-O3-S

Molecular Weight

384

Therapeutic Category

Antiarrhythmic agent, class III

Chemical Name

Methanesulfonamide, N-[4-[4-(ethylheptylamino)-1-hydroxybutyl]phenyl]-, (±)-

Foreign Names

  • Ibutilidum (Latin)
  • Ibutilid (German)
  • Ibutilide (French)
  • Ibutilida (Spanish)

Generic Names

  • Ibutilide (OS: BAN)
  • Ibutilide Fumarate (OS: BANM, USAN)
  • Ibutilid hemifumarat (IS)
  • U 70226 E (IS: Upjohn)

Brand Names

  • Corvert
    Alapis Pharma, Greece; Pfizer, Austria; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Finland; Pfizer, Netherlands; Pfizer, Norway; Pfizer, Sweden; Pfizer, United States; Pfizer Italia, Italy
  • Ibutilide Fumarate
    Bioniche, United States; Luitpold, United States

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web4)